Ceramides and sphingosine-1-phosphate as potential markers in diagnosis of ischaemic stroke

Anna Fiedorowicz; Anna Kozak-Sykała; Lukasz Bobak; Wojciech Kałas; Leon Strządała

doi:10.5603/pjnns.a2019.0063

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2019

Potential missed opportunities to prevent ischaemic stroke: prospective multicentre cohort study of atrial fibrillation-associated ischaemic stroke and TIA

Duncan Wilson, Gareth Ambler, Clare Shakeshaft, Gargi Banerjee, Andreas Charidimou, David Seiffge, Mark White, Hannah Cohen, Tarek Yousry, Rustam Al‐Shahi Salman, Professor Gregory Lip, Keith W. Muir, Martin M. Brown, Hans Rolf Jäger, David J. Werring

Article2019

Antagonism of Sphingosine-1-Phosphate Receptors Improves Macrophage Phagocytosis of Bacteria in COPD Patients

P.S. Fenwick, A. Newman Taylor, Jacquie Ujetz, Peter J Barnes, Louise Donnelly

Article2013

Reconceptualizing Adult Neurogenesis: Role for Sphingosine-1-Phosphate and Fibroblast Growth Factor-1 in Co-Ordinating Astrocyte-Neuronal Precursor Interactions

George Anderson, Michael Maes

Article2009

Genetic Association Studies in Ischaemic Stroke

D. Martijn O. Pruissen, L. Jaap Kappelle, Frits R. Rosendaal, Ale Algra

Cerebrovascular Diseases

Article2021

Atrioventricular block after fingolimod resumption: a consequence of sphingosine-1-phosphate axis alteration due to COVID-19?

Mario Orrico, Agostino Nozzolillo, Stefano Gelibter, Francesca Sangalli, Paolo Preziosa, Massimo Filippi, Lucia Moiola